An Explorative, Randomized, Placebo-controlled, DB, Parallel-group Trial, to Evaluate the Pharmacodynamic Effect of SPD557 on Reflux Parameters in Subjects With GERD & With Persistent Symptoms Despite Taking a Stable Dose of PPIs

Trial Profile

An Explorative, Randomized, Placebo-controlled, DB, Parallel-group Trial, to Evaluate the Pharmacodynamic Effect of SPD557 on Reflux Parameters in Subjects With GERD & With Persistent Symptoms Despite Taking a Stable Dose of PPIs

Discontinued
Phase of Trial: Phase II

Latest Information Update: 15 Sep 2014

At a glance

  • Drugs SPD 557 (Primary)
  • Indications Gastro-oesophageal reflux
  • Focus Pharmacodynamics; Therapeutic Use
  • Sponsors Shire
  • Most Recent Events

    • 06 Jun 2013 Status changed from completed to discontinued as reported by ClinicalTrials.gov.
    • 23 Jul 2012 Actual end date (May 2012) added as reported by ClinicalTrials.gov.
    • 23 Jul 2012 Actual patient number changed from 90 to 67 according to ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top